Abstract:Objective To evaluate the clinical value of contrast enhanced ultrasound(CEUS) for patients with hepatocellular carcinoma in identifying the ablation range and designing the treatment protocol before radiofrequency ablation(RFA) treatment and to compare the efficacy of RFA after CEUS with the efficacy of RFA after fundamental ultrasonography(US) without contrast.Methods One hundred sixty-one patients with hepatocellular carcinoma(HCC) were suitable for percutaneous RFA and underwent US-guided RFA treatment.CEUS was performed for 77 patients pre-treatment(CEUS group) and fundamental US without contrast enhancement was performed for the remaining 84 patients pre-treatment(non-CEUS group).There were no significant differences in clinical data between the two groups;the average diameters of the lesions in CEUS group and non-CEUS group were(3.6±1.2) cm and(3.5±1.1) cm,respectively.Regular follow-up after treatment was performed using fundamental US and contrast-enhanced computed tomography(CECT) or CEUS(or both).No residue or local recurrence on CECT at least 6 months after treatment was classified as complete ablation.Results In the CEUS group,77 cases with 105 lesions were treated with RFA.There were 59 lesions(56.2%) that were larger during the arterial phase and 49 lesions(46.7%) that had a more irregular shape during the arterial phase than in fundamental US.Feeding vessels were detected with CEUS in 37 of 52 lesions larger than 3.5 cm(71.1%).CEUS showed 16 small lesions(≤2.0 cm) in 10 cases,5 of which had 5 hepatic distant recurrences after RFA which coexisted with liver cirrhosis.Another 5 cases had 11 satellite lesions around the main tumor.The average number of RFA sessions in the CEUS group and non-CEUS group were 1.2 and 1.5 respectively.During the 6 to 36 months of follow-up,the complete ablation rate in the CEUS group was significantly higher than that in the non-CEUS group(95.4% vs 87.8%,P=0.042).The average survival time in the CEUS group was longer than that of non-CEUS group [(34.2±1.2) months vs(30.2±1.6) months,P=0.028].Conclusions CEUS is used to accurately identify the tumor invasive range and sensitively detect minute or satellite lesions and the feeding vessel of the tumor.CEUS provides important information and evidence for planning the RFA protocol and may improve the efficacy of RFA treatment of liver tumors.

Feasibility of 3D US/CEUS-US/CEUS fusion imaging-based ablation planning in liver tumors: a retrospective study

Three-dimensional ultrasound fusion imaging in precise needle placement for thermal ablation of hepatocellular carcinoma

Contrast-enhanced ultrasonography–CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome

Comparison of Real-Time Contrast-Enhanced Ultrasonography and Standard Ultrasonography in Liver Cancer Microwave Ablation

3D-CEUS/MRI–CEUS fusion imaging vs 2D-CEUS after locoregional therapies for hepatocellular carcinoma: a multicenter prospective study of therapeutic response evaluation

Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.

Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings

3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application

Clinical value of contrast enhanced ultrasound for identifying ablation range and designing treatment protocol of radiofrequency ablation in hepatocellular carcinoma

Contrast-enhanced ultrasonography guidance avoids US-CT/MR fusion error for percutaneous radiofrequency ablation of hepatocellular carcinoma

Radiofrequency ablation of small hepatic malignancies guided by contrast enhanced ultrasonography

3D US-Based Evaluation and Optimization of Tumor Coverage for US-Guided Percutaneous Liver Thermal Ablation

The Role of CEUS in Radiofrequency Ablation of HCC

Radiofrequency Ablation for Hepatocellular Carcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Guiding and Assessing Early Therapeutic Response and Short-Term Follow-Up Results

Ultrasound Fusion Imaging for Improving Diagnostic and Therapeutic Strategies of Focal Liver Lesions: A Preliminary Study.

Application of real time contrast-enhanced ultrasound guided radiofrequency ablation of hepatic malignances

Era of diagnostic and interventional ultrasound

Contrast-enhanced ultrasonography in the characterization of focal liver lesions before microwave ablation therapy

Improving Ablation Safety for Hepatocellular Carcinoma Proximal to the Hilar Bile Ducts by Ultrasound-MR Fusion Imaging: A Preliminary Comparative Study

CEUS-Based Radiomics Can Show Changes in Protein Levels in Liver Metastases after Incomplete Thermal Ablation.

Fusion Imaging-Guided Radiofrequency Ablation for Residual Hepatocellular Carcinoma Invisible on Ultrasound after Transcatheter Arterial Chemoembolization.